ADepT Therapy for Depression
This study is looking at a therapy called Augmented Depression Therapy (ADepT) for people experiencing a major depressive episode. ADepT is a type of behavioral therapy that combines different techniques to help manage depression symptoms and improve well-being. Researchers want to understand what patients think about ADepT and how effective it is. You might be able to join if you are 18-65 years old, have been diagnosed with a major depressive episode, and score above 10 on a depression questionnaire (PHQ-9). The study will measure how acceptable the therapy is, how many people complete it, and any side effects over 82 weeks.
- Study design
- This is an interventional study planning to enroll 40 participants. It is a case series, meaning it will observe the effects of ADepT on a group of individuals.
- What's involved
- You would attend 15 therapy sessions, typically weekly and lasting about 60 minutes each. You could also have up to 5 optional booster sessions over the next 12 months, each lasting about 60 minutes.
- Compensation
- Not stated in the trial record.
- Follow-up
- You would be followed from enrollment to the end of treatment, which is 82 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Augmented Depression Therapy (ADepT) Case Series
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- AcceptabilityFrom enrollment to the end of treatment at 82 weeks
Patient ratings of treatment acceptability
- AttritionFrom enrollment to the end of treatment at 82 weeks.
Patient attendance records
- Adverse EventsFrom enrollment to the end of treatment at 82 weeks.
Self-reported adverse events